An open-access scientific archive combining 12 years of multi-parameter daily vital sign telemetry (8,700+ blood pressure records, nocturnal SpO2, and medication logs) with continuous international trial intelligence from PubMed and ClinicalTrials.gov.
Weekly synthesis of new eosinophilic gastroenteritis & EGID studies from PubMed (96-gene CEDP panel, multidimensional remission in EoG/EoD, IL-33/ST2 skin-gut axis), AstraZeneca Tezepelumab Phase 3 CROSSING trial update, and patient community insights on post-remission visceral hypersensitivity.
Weekly synthesis of new eosinophilic gastroenteritis & EGID studies from PubMed, international clinical trials, and longitudinal real-world telemetry.
A comprehensive real-world patient comparative review of Nurtec (Rimegepant 75mg orally disintegrating tablet) versus Rayvow (Lasmiditan 50mg/100mg) for acute abortive and preventive treatment of episodic cluster headache.
A continuous 12-year longitudinal real-world study (4,389 days, 2014-2026) tracking daily blood pressure surges, SpO2, heart rate, and severe flare-ups in a patient diagnosed with Eosinophilic Gastroenteritis and multi-organ intractable allergies.
最新記事を読み込み中...